share_log
Reuters ·  May 2 02:40
Novo Nordisk CEO: We Don't See a Lot of Switching Amid U.s.patients From Wegovy to Rival Drug
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment